Собственность как объект мошенничества
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
346 1
Ultima descărcare din IBN:
2019-07-02 19:55
SM ISO690:2012
КРЫШЕВИЧ, Ольга. Собственность как объект мошенничества. In: Legea şi Viaţa. 2014, nr. 4/3(268), pp. 28-31. ISSN 1810-309X.
EXPORT metadate:
Google Scholar
Crossref
CERIF
BibTeX
DataCite
Dublin Core
Legea şi Viaţa
Numărul 4/3(268) / 2014 / ISSN 1810-309X

Собственность как объект мошенничества

Pag. 28-31

Крышевич Ольга
 
Национальная академия внутренних дел Украины
 
Disponibil în IBN: 19 septembrie 2014


Rezumat

В статье рассматривается собственность в экономическом и правовом содержании. Раскрывается понятийный аппарат собственности как объекта мошенничества, а именно родового и непосредственного объекта и вытекающего факультативного признака объекта – предмета. Особое внимание уделяется раскрытию системы признаков предмета мошенничества, в котором выделяются социальная, экономическая, физическая и правовая стороны имущества. При этом особое внимание уделяется рассмотрению предмета преступления мошенничества, а именно определению чужого имущества (движимое и недвижимое) и права на чужое имущество.

The article considers the property in the economic and legal content. Reveals the conceptual apparatus of the property as the object of fraud, namely generic and direct object and the resulting optional feature of the object – subject. Special attention is paid to development of the system of signs of fraud, which allocates social, economic, physical, and the legal side of the property. Special attention is paid to consideration of the subject of the crime fraud, namely the definition of someone else’s property (movable and immovable) and rights to property belonging to others.

Cuvinte-cheie
объект, собственность,

предмет, чужое имущество, право на чужое имущество.

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Nichitiuc, N.F.</creatorName>
</creator>
</creators>
<titles>
<title xml:lang='ru'>Клинические испытания иммунобиологических препаратов как основание для эффективной вакцинации</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2013</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1875-0666</relatedIdentifier>
<subjects>
<subject>vaccines</subject>
<subject>inclusion and exclusion criterias</subject>
<subject>immunization</subject>
<subject>safety.</subject>
</subjects>
<dates>
<date dateType='Issued'>2013-10-01</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'>The epidemiological situation referring to a number of infectious diseases, presenting manageable infections, requires more careful oversight, beginning with the preclinical and clinical studies, vaccine production, control of technological process and the serial production of the preparation and finishing with applying the product by the consumer. The effectiveness of immunization depends on a number of factors arising from the choice of the design of the drug clinical trials. Widely used in the medical practice newly created domestic vaccine preparations and oversea vaccine preparations, presented for the registration for the first time, require careful clinical study to examine their quality by defining security settings and immunologic efficiency. The expertise of immunobiological preparations is based on the evaluation of safety and efficacy, by which by the ratio of risk-benefit of the examined drug is determined. So, it is necessary to find the optimal design of the clinical trial that will objectively determine the ratio between the security and antigenic activity of the drug. The selection of volunteers for a clinical study is carried out on the basis of inclusion and exclusion criterias, taking into account legal and ethical principles, based on existing national equirements for the quality of medicines, and the principles of Helsinki
Declaration. During the clinical trials on vaccine preparations the selection of the optimal dosage and immunization scheme, the establishment of preventive vaccine effectiveness, the exploration of the possibility of expanding the indications for medical use and the identification of previously unknown side effects of registered vaccine preparations are performed. The organization and conduct of clinical trials of immunobiological preparations is a fundamental component in the system of epidemiological monitoring of vaccine preventable infections. A properly planned and administered
clinical trial of the vaccine products is a guarantee of the effectiveness of the population vaccination.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>